217 related articles for article (PubMed ID: 3722413)
21. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
Naik R; Baliga P; Bansal R; Pai M
J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
[TBL] [Abstract][Full Text] [Related]
22. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
23. [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers].
Horst HA; Horny HP; Gent HJ; Sellschopp C; Hedderich J
Klin Wochenschr; 1988 Dec; 66(23):1160-6. PubMed ID: 2850408
[TBL] [Abstract][Full Text] [Related]
24. A prognostic index based on the mean nuclear area of breast cancer cells and efferent vascular invasion in the axillary nodes.
Maehle BO; Skjaerven R
Diagn Histopathol; 1983; 6(3-4):221-8. PubMed ID: 6676076
[TBL] [Abstract][Full Text] [Related]
25. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM
Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639
[TBL] [Abstract][Full Text] [Related]
26. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors.
González-Vela MC; Garijo MF; Fernández FA; Buelta L; Val-Bernal JF
Pathol Res Pract; 1999; 195(9):611-8. PubMed ID: 10507081
[TBL] [Abstract][Full Text] [Related]
27. Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.
van der Linden JC; Baak JP; Postma T; Lindeman J; Meyer CJ
J Clin Pathol; 1985 Nov; 38(11):1229-34. PubMed ID: 4066982
[TBL] [Abstract][Full Text] [Related]
28. Histology in breast cancer prognosis.
Champion HR; Wallace IW; Prescott RJ
Br J Cancer; 1972 Apr; 26(2):129-38. PubMed ID: 4114100
[TBL] [Abstract][Full Text] [Related]
29. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
30. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
31. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
32. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
33. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
34. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients.
Hogan BV; Peter MB; Shenoy H; Horgan K; Shaaban A
Surg Oncol; 2010 Mar; 19(1):11-6. PubMed ID: 19171479
[TBL] [Abstract][Full Text] [Related]
35. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
36. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
[TBL] [Abstract][Full Text] [Related]
37. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
38. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
39. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.
Ladekarl M; Jensen V
Virchows Arch; 1995; 427(3):265-70. PubMed ID: 7496595
[TBL] [Abstract][Full Text] [Related]
40. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
